TCF4 induces enzalutamide resistance via neuroendocrine differentiation in prostate cancer
G. T. lee, W. T. Kim, Y. S. Kwon, G. Palapattu, W.-J. Kim, I. Y. Kim
This study identifies TCF4 as a driver of enzalutamide resistance in prostate cancer through neuroendocrine differentiation.
bioRxiv · Feb 25, 2019Cancer Biology